Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04613609 · ClinicalTrials.gov registry record · Early Phase 1
Vaporized Nicotine and Autonomic Control
A Early Phase 1 study of Electronic Cigarette Use, sponsored by Michigan Technological University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT04613609: Completed Early Phase 1 study of Electronic Cigarette Use, sponsored by Michigan Technological University.
NCT04613609 is a Early Phase 1 study of Electronic Cigarette Use that has completed, run by Michigan Technological University. The registered enrollment target is 16 participants, below the 212-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04613609, a Early Phase 1 study of Electronic Cigarette Use, has completed, sponsored by Michigan Technological University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
E-cigarettes are marketed as an alternative to smoking for those who want to decrease the health risks of tobacco. Tobacco cigarettes increase heart rate (HR) and arterial pressure, while reducing muscle sympathetic nerve activity (MSNA) through sympathetic baroreflex inhibition. The acute effects of e-cigarettes on arterial pressure and MSNA have not been reported: our purpose was to clarify this issue. Using a randomized crossover design, participants inhaled on a JUUL containing nicotine (59 mg/ml) and a similar placebo e-cigarette (0 mg/ml).
Primary Outcome
Effects of electronic cigarettes on both systolic and diastolic arterial pressure.
Conditions Studied
Interventions
- DEVICE Electronic Cigarette containing nicotine
- DEVICE Electronic Cigarette without nicotine
Study Locations (1)
Michigan
- Michigan Technological University - Houghton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2019-07-01 |
| Phase | Early Phase 1 |
What the finished NCT04613609 record still lists
NCT04613609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 212-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which Electronic Cigarette containing nicotine is the first listed.
NCT04613609 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04613609 about?
NCT04613609 is a clinical study titled "Vaporized Nicotine and Autonomic Control". E-cigarettes are marketed as an alternative to smoking for those who want to decrease the health risks of tobacco. Tobacco cigarettes increase heart rate (HR) and arterial pressure, while reducing muscle sympathetic nerve activity (MSNA) through sympathetic baroreflex inhibition. The acute effects o...
What is the current status of trial NCT04613609?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2018-04-01. Estimated completion is 2019-07-01.
What conditions does trial NCT04613609 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT04613609?
The interventions under investigation include: Electronic Cigarette containing nicotine (DEVICE), Electronic Cigarette without nicotine (DEVICE).
Who is sponsoring clinical trial NCT04613609?
This trial is sponsored by Michigan Technological University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04613609 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04613609's enrollment target sits among peer trials
16 15th of 15 higher than 1 of 15 other Electronic Cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Electronic Cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
RECRUITING · Early Phase 1
-
Effects of E-cigarette Use on Health
RECRUITING
-
Effects of Social Media Use on Young Adults' E-Cigarette Use
RECRUITING · NA
-
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
RECRUITING · NA
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI